Clinical trial
Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer
NCT00330161
Study timeline
Study start (unknown)2006-03-01Date precision: month
Registry last updated2014-05-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Recurrent Prostate Cancerunresolved
Stage IV Prostate Cancerunresolved
Interventions
vorinostatDRUG · verified · RxNorm: vorinostat
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00330161 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.